{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:38:53Z","timestamp":1791545933359,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005632","name":"Allergan plc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["archives-pmr.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Physical Medicine and Rehabilitation"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.apmr.2021.06.008","type":"journal-article","created":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T13:31:45Z","timestamp":1625664705000},"page":"2172-2184.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Real-World Adherence to OnabotulinumtoxinA Treatment for Spasticity: Insights From the ASPIRE Study"],"prefix":"10.1016","volume":"102","author":[{"given":"Alberto","family":"Esquenazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard E.","family":"Francisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuwei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Baricich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gallien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Fanning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksej","family":"Zuzek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Bandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George F.","family":"Wittenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apmr.2021.06.008_bib0001","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09638280400014576","article-title":"Spasticity: clinical perceptions, neurological realities and meaningful measurement","volume":"27","author":"Pandyan","year":"2005","journal-title":"Disabil Rehabil"},{"key":"10.1016\/j.apmr.2021.06.008_bib0002","first-page":"143","article-title":"[Research on a technic for measurement of spasticity] [French]","volume":"91","author":"Tardieu","year":"1954","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.apmr.2021.06.008_bib0003","unstructured":"Allergan. BOTOX\u00ae (onabotulinumtoxinA) [Package Insert]. Available at: https:\/\/media.allergan.com\/actavis\/actavis\/media\/allergan-pdf-documents\/product-prescribing\/20190620-BOTOX-100-and-200-Units-v3-0USPI1145-v2-0MG1145.pdf. Accessed December 17, 2019."},{"key":"10.1016\/j.apmr.2021.06.008_bib0004","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.toxicon.2012.11.025","article-title":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome","volume":"67","author":"Esquenazi","year":"2013","journal-title":"Toxicon"},{"issue":"Suppl 1","key":"10.1016\/j.apmr.2021.06.008_bib0005","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1468-1331.2006.01444.x","article-title":"Management of spasticity in adults: practical application of botulinum toxin","volume":"13","author":"Pathak","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.apmr.2021.06.008_bib0006","doi-asserted-by":"crossref","unstructured":"Li S, Francisco GE. The use of botulinum toxin for treatment of spasticity. In: Whitcup SM, Hallett M, editors. Botulinum toxin therapy. Handbook of Experimental Pharmacology. Vol 263. Cham; Springer: 2019.","DOI":"10.1007\/164_2019_315"},{"key":"10.1016\/j.apmr.2021.06.008_bib0008","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2340\/16501977-2245","article-title":"Adult Spasticity International Registry study: methodology and baseline patient, healthcare provider, and caregiver characteristics","volume":"49","author":"Francisco","year":"2017","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.apmr.2021.06.008_bib0009","first-page":"1","article-title":"Long-term observational results from the ASPIRE study: onabotulinumtoxinA treatment for adult lower limb spasticity","author":"Esquenazi","year":"2020","journal-title":"PM R"},{"key":"10.1016\/j.apmr.2021.06.008_bib0010","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/pmrj.12328","article-title":"Individualized onabotulinumtoxinA treatment for upper limb spasticity resulted in high clinician- and patient-reported satisfaction: long-term observational results from the ASPIRE study","volume":"12","author":"Francisco","year":"2020","journal-title":"PM R"},{"key":"10.1016\/j.apmr.2021.06.008_bib0011","article-title":"High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study","volume":"7","author":"Francisco","year":"2020","journal-title":"Toxicon: X"},{"key":"10.1016\/j.apmr.2021.06.008_bib0012","unstructured":"Allergan. BOTOX\u00ae 100 units summary of product characteristics (SmPC). Available at: https:\/\/www.medicines.org.uk\/emc\/product\/859\/smpc. Accessed December 17, 2019."},{"key":"10.1016\/j.apmr.2021.06.008_bib0013","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1053\/apmr.2002.35474","article-title":"Inter- and intrarater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upper-limb poststroke spasticity","volume":"83","author":"Brashear","year":"2002","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2021.06.008_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001394","article-title":"Comparing the validity of the Modified Modified Ashworth Scale (MMAS) and the Modified Tardieu Scale (MTS) in the assessment of wrist flexor spasticity in patients with stroke: protocol for a neurophysiological study","volume":"2","author":"Abolhasani","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.apmr.2021.06.008_bib0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/09593980701523802","article-title":"Inter- and intrarater reliability of the Modified Modified Ashworth Scale in patients with knee extensor poststroke spasticity","volume":"24","author":"Ansari","year":"2008","journal-title":"Physiother Theory Pract"},{"key":"10.1016\/j.apmr.2021.06.008_bib0016","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.apmr.2021.06.008_bib0017","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1097\/ALN.0b013e3181de0e6d","article-title":"A comparison of change in the 0-10 numeric rating scale to a pain relief scale and global medication performance scale in a short-term clinical trial of breakthrough pain intensity","volume":"112","author":"Farrar","year":"2010","journal-title":"Anesthesiology"},{"issue":"Suppl 6","key":"10.1016\/j.apmr.2021.06.008_bib0018","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00415-008-6016-8","article-title":"Compliance, adherence, and the treatment of multiple sclerosis","volume":"255","author":"Klauer","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.apmr.2021.06.008_bib0019","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.pmrj.2013.04.022","article-title":"Adherence associated with oral medications in the treatment of spasticity","volume":"5","author":"Halpern","year":"2013","journal-title":"PM R"},{"issue":"Suppl 19","key":"10.1016\/j.apmr.2021.06.008_bib0020","first-page":"S539","article-title":"Intrathecal baclofen therapy for spasticity: a compliance-based study to indicate effectiveness","volume":"7","author":"Abou Al-Shaar","year":"2016","journal-title":"Surg Neurol Int"},{"key":"10.1016\/j.apmr.2021.06.008_bib0021","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1007\/s10072-017-3078-3","article-title":"Determinants of botulinum toxin discontinuation in multiple sclerosis: a retrospective study","volume":"38","author":"Latino","year":"2017","journal-title":"Neurol Sci"},{"key":"10.1016\/j.apmr.2021.06.008_bib0022","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/acn3.51225","article-title":"Long-term adherence and response to botulinum toxin in different indications","volume":"8","author":"Lee","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.apmr.2021.06.008_bib0023","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1191\/1352458504ms1085oa","article-title":"Prevalence and treatment of spasticity reported by multiple sclerosis patients","volume":"10","author":"Rizzo","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.apmr.2021.06.008_bib0024","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000375397","article-title":"Post stroke pain: identification, assessment, and therapy","volume":"39","author":"Harrison","year":"2015","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.apmr.2021.06.008_bib0025","first-page":"1","article-title":"The complexities of pain after stroke\u2014a review with a focus on central post-stroke pain","volume":"55","author":"Seifert","year":"2013","journal-title":"Panminerva Med"},{"key":"10.1016\/j.apmr.2021.06.008_bib0026","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0885-3924(00)00146-9","article-title":"Management of spasticity associated pain with botulinum toxin A","volume":"20","author":"Wissel","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.apmr.2021.06.008_bib0027","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/PHM.0b013e31824fa9ca","article-title":"Patient registry of outcomes in spasticity care","volume":"91","author":"Esquenazi","year":"2012","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2021.06.008_bib0028","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0003-9993(96)90015-5","article-title":"Botulinum toxin A in the treatment of spasticity: functional implications and patient selection","volume":"77","author":"Pierson","year":"1996","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2021.06.008_bib0029","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/jnnp.61.1.30","article-title":"Use of botulinum toxin in stroke patients with severe upper limb spasticity","volume":"61","author":"Bhakta","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.apmr.2021.06.008_bib0030","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1177\/0269215513491274","article-title":"The efficacy of botulinum toxin A for spasticity and pain in adults: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach","volume":"27","author":"Baker","year":"2013","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.apmr.2021.06.008_bib0031","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpainsymman.2016.01.007","article-title":"OnabotulinumtoxinA improves pain in patients with post-stroke spasticity: findings from a randomized, double-blind, placebo-controlled trial","volume":"52","author":"Wissel","year":"2016","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.apmr.2021.06.008_bib0032","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1161\/01.STR.0000180861.54180.FF","article-title":"Management of adult stroke rehabilitation care: a clinical practice guideline","volume":"36","author":"Duncan","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.apmr.2021.06.008_bib0033","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1161\/STROKEAHA.109.559864","article-title":"Medial medullary infarction: clinical, imaging, and outcome study in 86 consecutive patients","volume":"40","author":"Kim","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.apmr.2021.06.008_bib0034","first-page":"361","article-title":"[The clinical, radiological and prognostic factor analysis of medullary infarction] [Chinese]","volume":"55","author":"Sun","year":"2016","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"Suppl 1","key":"10.1016\/j.apmr.2021.06.008_bib0035","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.msard.2016.07.003","article-title":"Brain health: time matters in multiple sclerosis","volume":"9","author":"Giovannoni","year":"2016","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.apmr.2021.06.008_bib0036","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/ane.12202","article-title":"Spasticity in patients with multiple sclerosis\u2014clinical characteristics, treatment and quality of life","volume":"129","author":"Flachenecker","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.apmr.2021.06.008_bib0037","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1047-9651(03)00093-7","article-title":"Muscle overactivity and movement dysfunction in the upper motoneuron syndrome","volume":"14","author":"Mayer","year":"2003","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"10.1016\/j.apmr.2021.06.008_bib0038","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1212\/01.WNL.0000156520.46056.6B","article-title":"Pure midbrain infarction: clinical, radiologic, and pathophysiologic findings","volume":"64","author":"Kim","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.apmr.2021.06.008_bib0039","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000334105","article-title":"Clinical study of twenty-one patients with pure midbrain infarction","volume":"67","author":"Ogawa","year":"2012","journal-title":"Eur Neurol"},{"key":"10.1016\/j.apmr.2021.06.008_bib0040","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pmr.2018.03.004","article-title":"Muscle overactivity in the upper motor neuron syndrome: conceptualizing a treatment plan and establishing meaningful goals","volume":"29","author":"Ambrose","year":"2018","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"10.1016\/j.apmr.2021.06.008_bib0041","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.toxicon.2020.10.005","article-title":"Peri-operative botulinum neurotoxin injection to improve outcomes of surgeries on spastic limbs: a systematic review","volume":"188","author":"Saeidiborojeni","year":"2020","journal-title":"Toxicon"},{"key":"10.1016\/j.apmr.2021.06.008_bib0042","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2340\/16501977-2226","article-title":"Assessment and treatment of spastic equinovarus foot after stroke: guidance from the Mont-Godinne interdisciplinary group","volume":"49","author":"Deltombe","year":"2017","journal-title":"J Rehabil Med"},{"key":"10.1016\/j.apmr.2021.06.008_bib0043","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1097\/PHM.0000000000001459","article-title":"A retrospective analysis of factors impacting rehabilitation outcomes in patients with spontaneous intracerebral hemorrhage","volume":"99","author":"Zhao","year":"2020","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.apmr.2021.06.008_bib0044","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12877-016-0187-4","article-title":"Factors influencing home discharge after inpatient rehabilitation of older patients: a systematic review","volume":"16","author":"Everink","year":"2016","journal-title":"BMC Geriatr"}],"container-title":["Archives of Physical Medicine and Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003999321004974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003999321004974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T07:08:23Z","timestamp":1757747303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003999321004974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0003999321004974"],"URL":"https:\/\/doi.org\/10.1016\/j.apmr.2021.06.008","relation":{},"ISSN":["0003-9993"],"issn-type":[{"value":"0003-9993","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-World Adherence to OnabotulinumtoxinA Treatment for Spasticity: Insights From the ASPIRE Study","name":"articletitle","label":"Article Title"},{"value":"Archives of Physical Medicine and Rehabilitation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apmr.2021.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of The American Congress of Rehabilitation Medicine.","name":"copyright","label":"Copyright"}]}}